BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 18574672)

  • 1. Biochemical characterization of CK2alpha and alpha' paralogues and their derived holoenzymes: evidence for the existence of a heterotrimeric CK2alpha'-holoenzyme forming trimeric complexes.
    Olsen BB; Rasmussen T; Niefind K; Issinger OG
    Mol Cell Biochem; 2008 Sep; 316(1-2):37-47. PubMed ID: 18574672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward selective CK2alpha and CK2alpha' inhibitors: Development of a novel whole-cell kinase assay by Autodisplay of catalytic CK2alpha'.
    Bollacke A; Nienberg C; Borgne ML; Jose J
    J Pharm Biomed Anal; 2016 Mar; 121():253-260. PubMed ID: 26786382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of the CK2alpha'-based holoenzyme, an isozyme of CK2alpha: a comparative analysis.
    Olsen BB; Boldyreff B; Niefind K; Issinger OG
    Protein Expr Purif; 2006 Jun; 47(2):651-61. PubMed ID: 16442308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the human protein kinase CK2 catalytic subunit CK2α' and interaction thermodynamics with the regulatory subunit CK2β.
    Bischoff N; Olsen B; Raaf J; Bretner M; Issinger OG; Niefind K
    J Mol Biol; 2011 Mar; 407(1):1-12. PubMed ID: 21241709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein Kinase CK2α', More than a Backup of CK2α.
    Montenarh M; Götz C
    Cells; 2023 Dec; 12(24):. PubMed ID: 38132153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential localization of alpha' and beta subunits of protein kinase CK2 during rat spermatogenesis.
    Alvarado-Díaz CP; Tapia JC; Antonelli M; Moreno RD
    Cell Tissue Res; 2009 Oct; 338(1):139-49. PubMed ID: 19711102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory influence of natural flavonoids on human protein kinase CK2 isoforms: effect of the regulatory subunit.
    Baier A; Nazaruk J; Galicka A; Szyszka R
    Mol Cell Biochem; 2018 Jul; 444(1-2):35-42. PubMed ID: 29188536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kinesin I family member KIF5C is a novel substrate for protein kinase CK2.
    Schäfer B; Götz C; Montenarh M
    Biochem Biophys Res Commun; 2008 Oct; 375(2):179-83. PubMed ID: 18682247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of plant-specific N-terminal domain of maize CK2β1 subunit in CK2β functions and holoenzyme regulation.
    Riera M; Irar S; Vélez-Bermúdez IC; Carretero-Paulet L; Lumbreras V; Pagès M
    PLoS One; 2011; 6(7):e21909. PubMed ID: 21789193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A N-terminally deleted form of the CK2α' catalytic subunit is sufficient to support cell viability.
    Borgo C; D'Amore C; Cesaro L; Itami K; Hirota T; Salvi M; Pinna LA
    Biochem Biophys Res Commun; 2020 Oct; 531(3):409-415. PubMed ID: 32800562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase CK2alpha' is induced by serum as a delayed early gene and cooperates with Ha-ras in fibroblast transformation.
    Orlandini M; Semplici F; Ferruzzi R; Meggio F; Pinna LA; Oliviero S
    J Biol Chem; 1998 Aug; 273(33):21291-7. PubMed ID: 9694889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selected flavonoid compounds as promising inhibitors of protein kinase CK2α and CK2α', the catalytic subunits of CK2.
    Baier A; Galicka A; Nazaruk J; Szyszka R
    Phytochemistry; 2017 Apr; 136():39-45. PubMed ID: 28043654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary and secondary interactions between CK2alpha and CK2beta lead to ring-like structures in the crystals of the CK2 holoenzyme.
    Niefind K; Issinger OG
    Mol Cell Biochem; 2005 Jun; 274(1-2):3-14. PubMed ID: 16335523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and SAR of Tetracyclic Inhibitors of Protein Kinase CK2 Derived from Furocarbazole W16.
    Kröger L; Daniliuc CG; Ensan D; Borgert S; Nienberg C; Lauwers M; Steinkrüger M; Jose J; Pietsch M; Wünsch B
    ChemMedChem; 2020 May; 15(10):871-881. PubMed ID: 32168422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of a CK2α subunit and the holoenzyme from the mussel Mytilus galloprovincialis and construction of the CK2α and CK2β cDNAs.
    Kolaiti RM; Baier A; Szyszka R; Kouyanou-Koutsoukou S
    Mar Biotechnol (NY); 2011 Jun; 13(3):505-16. PubMed ID: 20922551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CK2 kinase activity but not its binding to CK2 promoter regions is implicated in the regulation of CK2α and CK2β gene expressions.
    Lupp S; Gumhold C; Ampofo E; Montenarh M; Rother K
    Mol Cell Biochem; 2013 Dec; 384(1-2):71-82. PubMed ID: 23963994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical characterization of the recombinant human Drosophila homologues Timekeeper and Andante involved in the Drosophila circadian oscillator.
    Rasmussen T; Skjøth IH; Jensen HH; Niefind K; Boldyreff B; Issinger OG
    Mol Cell Biochem; 2005 Jun; 274(1-2):151-61. PubMed ID: 16335535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protein kinase CK2(Andante) holoenzyme structure supports proposed models of autoregulation and trans-autophosphorylation.
    Schnitzler A; Olsen BB; Issinger OG; Niefind K
    J Mol Biol; 2014 May; 426(9):1871-82. PubMed ID: 24594356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing the convergence of protein kinase CK2 and caspase-3 reveals isoform-specific phosphorylation of caspase-3 by CK2α': implications for pathological roles of CK2 in promoting cancer cell survival.
    Turowec JP; Vilk G; Gabriel M; Litchfield DW
    Oncotarget; 2013 Apr; 4(4):560-71. PubMed ID: 23599180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of thymidylate synthase from various sources by human protein kinase CK2 and its catalytic subunits.
    Fraczyk T; Kubiński K; Masłyk M; Cieśla J; Hellman U; Shugar D; Rode W
    Bioorg Chem; 2010 Jun; 38(3):124-31. PubMed ID: 20199796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.